MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-WB-10-0018958
Pharma Impex Laboratories Pvt Ltd - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹101.54 Cr
▲ 12% YoY
Net profit · FY 2024
₹4.42 Cr
Net margin 4.4%
EBITDA · FY 2024
₹10.43 Cr
EBITDA margin 10.3%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹10 Cr
Issued & subscribed
Open charges
₹44.85 Cr
Satisfied ₹69.76 Cr
Company age
49 yrs
Est. 1977
Employees · EPFO
96
Provident fund records
About Pharma Impex Laboratories Pvt Ltd
Data last updated:
Pharma Impex Laboratories Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 October 1977 and has been in existence for over 49 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1977PTC031208. Its GSTIN is 19AACCP1511G1ZS (West Bengal).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹10 Cr. It is led by directors including Manoj Gupta (Managing Director) and Swati Gupta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1st Floor 10C Middleton Row, Kolkata, West Bengal, India – 700071.
As per the financials filed for FY 2024, the company reported a revenue of ₹101.54 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹4.42 Cr (net margin 4.4%) and EBITDA of ₹10.43 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 18% over five years.
The company has about 96 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹44.85 Cr and satisfied charges of ₹69.76 Cr on record. Court records list 26 cases involving the company, including 9 filed by the company and 17 filed against it; 12 cases are pending. The company has 11 deals on record (8 secondary share transfers, 3 rights issues); the latest was in March 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Makson Industries Private Limited with revenue of ₹101.93 Cr.
Pharma Impex Laboratories Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0018958). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmaimpexlab.com.
Company details
CIN U24231WB1977PTC031208
Registration Number 031208
Incorporation Date 18 October 1977
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-WB-10-0018958
Key People
Manoj Gupta Managing Director Swati Gupta Whole-Time Director Aryaman Gupta Additional Director Recognitions & Rankings of Pharma Impex Laboratories
Contact details
Pharma Impex Laboratories Pvt Ltd's registered office is in Kolkata, West Bengal. Its website is pharmaimpexlab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor 10C Middleton Row, Kolkata, West Bengal, India – 700071
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Comprehensive company report
Pharma Impex Laboratories Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pharma Impex Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Financials of Pharma Impex Laboratories Pvt Ltd
FY 2024 filings availablePharma Impex Laboratories Pvt Ltd reported revenue of ₹101.54 Cr (up 12% YoY) for FY 2024.
Revenue · FY 2024
₹101.54 Cr ▲ 12%
Net profit · FY 2024
₹4.42 Cr margin 4.4%
EBITDA · FY 2024
₹10.43 Cr margin 10.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 22%
5 years · compounded
▲ 18%
EBITDA CAGR growth
3 years · compounded
▲ 4%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 12% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹101.54 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Board of directors of Pharma Impex Laboratories Pvt Ltd
Pharma Impex Laboratories has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Gupta | Managing Director | 08 Oct 1997 | 29 Years 0 Months | Current |
| Swati Gupta | Whole-Time Director | 15 Nov 2016 | 9 Years 11 Months | Current |
| Aryaman Gupta | Additional Director | 26 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Pharma Impex Laboratories Pvt Ltd is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Makson Industries Private Limited | ₹101.93 Cr (FY 2018) | 4.0% | Mandideep, Madhya Pradesh, India | |||
| Maan Pharmaceuticals Ltd | ₹101.88 Cr (FY 2025) | -4.0% | Ahmedabad, Gujarat, India | |||
| Bueno Salud Care (India) Private Limited | ₹101.84 Cr (FY 2025) | 30.0% | Ahmedabad, Gujarat, India | |||
| Sachin Parenteral Private Limited | ₹101.7 Cr (FY 2025) | 82.0% | Aligarh, Uttar Pradesh, India | |||
| Pharma Impex Laboratories Pvt Ltdthis company | ₹101.54 Cr (FY 2024) | ₹4.42 Cr | 4.4% | 12.0% | 96 | Kolkata, West Bengal, India |
| Samrudh Pharmaceuticals Private Limited | ₹101.47 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Nabros Pharma Private Limited | ₹101.03 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Instapill Private Limited | ₹100.92 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India | |||
| Sotac Pharmaceuticals Limited | ₹100.88 Cr (FY 2025) | -3.0% | Sanand, Gujarat, India |
To see the full peer comparison of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Auditor
Pharma Impex Laboratories Pvt Ltd is audited by DANGI JAIN & COMPANY for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DANGI JAIN & COMPANY | FY 2024 | 308108E |
Shareholding
The shareholding of Pharma Impex Laboratories Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹44.85 Cr
Satisfied charges
₹69.76 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2025 | 101089234 | Hdfc Bank Limited | ₹5 Cr | Open | |
| 09 Feb 2023 | 100692055 | Others | ₹6.81 Cr | Open | |
| 09 Feb 2023 | 100692084 | Others | ₹13 Cr | Open | |
| 01 Sep 2021 | 100474549 | Sidbi | ₹4.29 Cr | Open | |
| 19 Jul 2021 | 100473957 | Axis Bank Limited | ₹15.75 Cr | Open |
To see the full charge records of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Pharma Impex Laboratories Pvt Ltd has 11 deals on record (8 secondary share transfers, 3 rights issues); the latest was in March 2024.
Total deals
11
Secondary share transfers
8
Rights issues
3
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2020 | Rights issue | ₹2 Cr | Investors: an individual |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Mar 2018 | Rights issue | ₹1 Cr | Investors: an individual |
To see the full deal history of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pharma Impex Laboratories Pvt Ltd has 26 court cases on record: 9 filed by Pharma Impex Laboratories, 17 filed against it. 12 cases are pending and 14 are disposed.
Total cases
26
Filed by the company
9
Filed against the company
17
Pending
12
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 13 | 9 |
| High courts | 10 | 4 | 3 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Writ petition | Filed by the company against West Bengal Small Industries Development Corporation Limited and Ors | Pending |
| High Court, Rajasthan | Court case (CFA) | Filed against the company by M/S Dalas Biotech Limited | Pending |
| High Court | Court case (CRES) | Filed against the company by M/S Dalas Biotech Limited, | Disposed |
| High Court | Court case (CMCC) | Filed against the company by M/S Dalas Biotech Limited, | Disposed |
| District court, Mahabubnagar, Telangana | Criminal complaint | Filed against the company by Union of India Rep by Drugs Inspector | Pending |
To see the full case history of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Pharma Impex Laboratories Pvt Ltd was last rated by Care on 01 Sep 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 01 Sep 2022 |
To see the full credit ratings and regulatory alerts of Pharma Impex Laboratories Pvt Ltd, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharma Impex Laboratories Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharma Impex Laboratories Pvt Ltd has a workforce of 96 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.
Employee count
96
Active EPFO establishments
1
Employee growth
7.87%
GST
Pharma Impex Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCP1511G1ZS | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharma Impex Laboratories Pvt Ltd, buy the company report.
Recent activity
Pharma Impex Laboratories Pvt Ltd has 11 board changes on record since 1997: 3 appointments and 8 cessations. The latest: Aryaman Gupta was appointed as Additional Director on 26 Nov 2025.
Appointed
Aryaman Gupta was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101089234 was registered on 28 Mar 2025.
AGM
Pharma Impex Laboratories Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Pharma Impex Laboratories Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
Charges
A charge with Sidbi of Rs. 4.29 Cr registered on 01 Sep 2021 with Charge ID 100474549 was modified on 22 Nov 2023.
Charges
A charge with Others of Rs. 6.81 Cr registered on 09 Feb 2023 with Charge ID 100692055 was modified on 13 Nov 2023.
Charges
A charge with Others of Rs. 13.00 Cr registered on 09 Feb 2023 with Charge ID 100692084 was modified on 13 Nov 2023.
Charges
A charge registered on 25 Sep 2019 via Charge ID 100295777 with Others was fully satisfied on 01 Jun 2023.
Charges
A charge with Others amounted to Rs. 6.81 Cr with Charge ID 100692055 was registered on 09 Feb 2023.
Charges
A charge with Others amounted to Rs. 13.00 Cr with Charge ID 100692084 was registered on 09 Feb 2023.
Charges
A charge with Axis Bank Limited of Rs. 15.75 Cr registered on 19 Jul 2021 with Charge ID 100473957 was modified on 10 Jan 2023.
Ceased
Arvind Khaitan ceased to be Director.
27 earlier events are in the company report.
Frequently asked questions
Pharma Impex Laboratories is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 October 1977 (49+ years old) and is registered under CIN U24231WB1977PTC031208.
Pharma Impex Laboratories has 3 current directors:
- Manoj Gupta - Managing Director
- Swati Gupta - Whole-Time Director
- Aryaman Gupta - Additional Director
The latest financial statements of Pharma Impex Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharma Impex Laboratories is 19AACCP1511G1ZS, registered in West Bengal.
The CIN (Corporate Identification Number) of Pharma Impex Laboratories is U24231WB1977PTC031208. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharma Impex Laboratories has 26 court cases on record: 9 filed by the company and 17 filed against it. 12 are pending. Most are in the district courts.
Pharma Impex Laboratories was incorporated on 18 October 1977, making it 49+ years old. It is registered with the Registrar of Companies, Kolkata.
Pharma Impex Laboratories has 11 deals on record (8 secondary share transfers, 3 rights issues); the latest was in March 2024.
The peers of Pharma Impex Laboratories by revenue are Makson Industries Private Limited, Maan Pharmaceuticals Ltd, Bueno Salud Care (India) Private Limited, Sachin Parenteral Private Limited, Samrudh Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aryaman Gupta was appointed as Additional Director on 26 Nov 2025. Arvind Khaitan ceased to be Director on 03 Sep 2021. Abhishek Saraogi ceased to be Additional Director on 31 Dec 2020. Pharma Impex Laboratories has 11 board changes on record in total.
Yes, Pharma Impex Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-WB-10-0018958).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages